PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 62 filers reported holding PLIANT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,251,692 | +12.2% | 418,206 | +17.2% | 0.00% | 0.0% |
| Q2 2023 | $6,465,760 | +12.3% | 356,830 | +64.8% | 0.00% | 0.0% |
| Q1 2023 | $5,759,326 | +72.6% | 216,516 | +25.4% | 0.00% | +100.0% |
| Q4 2022 | $3,337,440 | -5.4% | 172,656 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $3,528,000 | +355.8% | 168,878 | +74.9% | 0.00% | – |
| Q2 2022 | $774,000 | -33.8% | 96,542 | -42.1% | 0.00% | – |
| Q1 2022 | $1,170,000 | -46.5% | 166,777 | +3.0% | 0.00% | -100.0% |
| Q4 2021 | $2,187,000 | -18.1% | 161,988 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $2,670,000 | -3.4% | 158,161 | +66.7% | 0.00% | 0.0% |
| Q2 2021 | $2,763,000 | -24.9% | 94,879 | +1.5% | 0.00% | 0.0% |
| Q1 2021 | $3,679,000 | +153.2% | 93,521 | +46.3% | 0.00% | 0.0% |
| Q4 2020 | $1,453,000 | +1.8% | 63,945 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $1,428,000 | – | 63,012 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |